Pacira BioSciences, Inc. (PCRX)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	-68,733	-59,471	97,777	106,679	103,712	86,854	80,644	52,675	57,920	45,024	64,946	87,881	89,925	104,496	90,683	48,693	46,350	29,279	14,072	26,494
Total assets	US$ in thousands	1,553,520	1,521,690	1,646,820	1,583,320	1,574,390	1,534,460	1,542,380	1,523,420	1,681,200	1,734,360	1,733,990	1,891,480	2,075,350	1,356,000	1,325,830	1,287,550	1,274,510	1,220,270	866,111	821,379
Operating ROA		-4.42%	-3.91%	5.94%	6.74%	6.59%	5.66%	5.23%	3.46%	3.45%	2.60%	3.75%	4.65%	4.33%	7.71%	6.84%	3.78%	3.64%	2.40%	1.62%	3.23%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $-68,733K ÷ $1,553,520K
= -4.42%

Operating ROA measures how efficiently a company generates operating profit relative to its total assets. For Pacira BioSciences, Inc., the operating ROA has fluctuated over the quarters. The trend shows an improvement in performance from June 2020 to June 2021, with operating ROA increasing steadily. However, there was a decline in the following quarters up to December 2022. Notably, there was a sudden negative turn in the last two quarters of 2024, indicating a decrease in operating efficiency as the company may not be effectively utilizing its assets to generate operating profits.

It is important for stakeholders to closely monitor Pacira BioSciences' operating ROA trends to assess its operational efficiency and ensure sustainable profitability in the long term. Further analysis and investigation into the factors leading to the negative operating ROA could provide insights for potential improvements in asset utilization and operational management.